Filetype PDF | Posted on 03 Oct 2022 | 3 years ago
Authentication
digital resources
189x Filetype PDF File size 0.30 MB Source: global.oup.com
Oxford Handbook of Clinical Medicine, 9th Edition - Chapter 8 references
Page No Final Ref No. Bibliographic information Website link (if applicable)
Microcytosis, iron deficiency and thalassaemia in a multi-ethnic community: a pilot
study. Author: Wonke B, Modell M, Marlow T, Khan M, Modell B. Journal: Scand J Clin
318 1 Lab Invest; 2007 ; 67(1):87-95. PubMed ID: 17365986. http://www.ncbi.nlm.nih.gov/pubmed/?term=17365986
Hill SR, Carless PA, Henry DA, Carson JL, Hebert PC, McClelland DB, Henderson KM.
Transfusion thresholds and other strategies for guiding allogeneic red blood cell
318 2 transfusion. Cochrane Database Syst Rev. 2002;(2):CD002042. Review. http://www.ncbi.nlm.nih.gov/pubmed/12076437
The investigation and treatment of secondary anaemia. Authors Davis SL, et al. Show
3 all Journal Blood Rev. 2012 Mar;26(2):65-71. http://www.ncbi.nlm.nih.gov/pubmed/?term=22133555
Anaemia in rheumatoid arthritis: can we afford to ignore it? Authors Bloxham E, et al.
Show all Journal Postgrad Med J. 2011 Sep;87(1031):596-600. doi:
4 10.1136/pgmj.2011.117507. http://www.ncbi.nlm.nih.gov/pubmed/?term=21659451
http://www.nature.com/bjc/journal/v88/n7/abs/6600801
320 5 Br J cancer 2003;88:988-95. a.html
Diagnosis and management of anaemia of chronic disease: current status. Authors
Cullis JO. Journal Br J Haematol. 2011 Aug;154(3):289-300. doi: 10.1111/j.1365-
6 2141.2011.08741.x. Epub 2011 May 25. http://www.ncbi.nlm.nih.gov/pubmed/?term=21615381
BMJ 2006;333:791-793 (14 October), doi:10.1136/bmj.38979.358032.BE .Cases in
primary care laboratory medicine Investigating iron status in microcytic anaemia. http://www.bmj.com/cgi/content/full/333/7572/791?view
320 7 Michael J Galloway =long&pmid=17038737
Yates JM, Logan EC, Stewart RM. Iron deficiency anaemia in general practice: clinical
outcomes over three years and factors influencing diagnostic investigations. Postgrad
320 8 Med J. 2004; 80: 405-10. http://www.ncbi.nlm.nih.gov/pubmed/?term=15254305
Hardwick RH, Armstrong CP. Synchronous upper and lower gastrointestinal
endoscopy is an effective method of investigating iron-deficiency anaemia. Br J Surg
320 9 1997; 84: 1725-8. http://www.ncbi.nlm.nih.gov/pubmed/?term=9448626
Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation.
Authors Fleming MD. Journal Hematology Am Soc Hematol Educ Program.
11 2011;2011:525-31. http://www.ncbi.nlm.nih.gov/pubmed/?term=22160084
Blood. 2003 Mar 1;101(5):1996-2000. Epub 2002 Oct 24. Mitochondrial ferritin
321 10 expression in erythroid cells from patients with sideroblastic anemia. http://www.ncbi.nlm.nih.gov/pubmed/12406866
A medical mystery. Lead poisoning. Author: van der Klooster JM. Journal: Singapore
322 12 Med J; 2004 Oct ; 45(10):497-9. PubMed ID: 15455173. http://www.ncbi.nlm.nih.gov/pubmed/?term=15455173
Leukoerythroblastic syndrome associated with visceral leishmaniasis] Author: Portilla
Sogorb J, Jover JM, Pertusa S, Cabezas A.Journal: Rev Clin Esp; 1991 Dec ; 189(9):447-
322 13 8. PubMed ID: 1792383. http://www.ncbi.nlm.nih.gov/pubmed/?term=1792383
Ulcerative colitis complicated by a leucoerythroblastic anaemia. Author: Chesner IM,
322 14 Gozzard DI. Journal: Postgrad Med J; 1982 Oct ; 58(684):662-4. PubMed ID: 7177992. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426482/
http://www.wadsworth.org/chemheme/heme/cytoheme/
323 15 Wadsworth Centre, case presentation, commentary to slide number 138 ans138.htm
Cabot’s Aphorisms collected by Phil Freed. Quoted by David Segal in Journal of Chronic
323 16 Diseases. 1963; 16: 443. http://www.whonamedit.com/doctor.cfm/1906.html
323 17 B Bain 1999 nejm 1999 341 1141 and 1060; no link available;
J Leone 2000 nejm 342 442 and 1061 The Spry definition of eosinophilia: counts of
0.55 ´ 109 to 1.5 ´ 109/L `need follow-up’; counts of 1.5 ´ 109 to 10 ´ 109/L `need
investigation soon’, and counts of >10 ´ 109/L `need urgent assessment’—including
324 18 cardiac; no link available; http://www.ncbi.nlm.nih.gov/pubmed/12856373
Rothenberg M 2008. Treatment of Patients with the hypereosinophilic syndrome with
324 19 mepolizumab. NEJM 358 1215. http://www.nejm.org
Davey Smith G, Ebrahim S. Folate supplementation and cardiovascular disease. Lancet http://www.thelancet.com/journals/lancet/article/PIIS014
326 20 2005; 366: 1679-1681. 0673605676763/fulltext
Lewis SJ, Ebrahim S, Davey Smith G. Meta-analysis of MTHFR 677C->T polymorphism
and coronary heart disease: does totality of evidence support causal role for
326 21 homocysteine and preventive potential of folate? BMJ. 2005; 331 (7524): 1053. http://www.ncbi.nlm.nih.gov/pubmed/?term=16216822
326 22 J Durga 2007 Lancet 369 208; no link available; http://www.ncbi.nlm.nih.gov/pubmed/17240287
http://www.sciencedirect.com/science?_ob=ArticleURL&_
udi=B7J28-4FM5464-
1&_user=10&_coverDate=01%2F01%2F2005&_rdoc=1&_f
mt=&_orig=search&_sort=d&view=c&_acct=C000050221&
Respiratory Medicine 2005 S Yurt. Two cases of pulmonary tuberculosis with _version=1&_urlVersion=0&_userid=10&md5=ad1e261524
329 23 extrapulmonary involvement in tongue and anus 17186526c6e65d6c120fac
Drug and Therapeutics Bulletin 2009; Oral or Intramuscular B12. 47:19-21;
329 24 doi:10.1136/dtb.2009.01.0002 http://dtb.bmj.com/cgi/content/abstract/47/2/19
Update on oral cyanocobalamin (vitamin b(12)) treatment in elderly patients. Author:
Andrès E, Vogel T, Federici L, Zimmer J, Kaltenbach G. Journal: Drugs Aging; 2008 ;
329 25 25(11):927-32. PubMed ID: 18947260. http://www.ncbi.nlm.nih.gov/pubmed/?term=18947260
Management of pregnancies complicated by anti-c isoimmunization. Author: Hackney
DN, Knudtson EJ, Rossi KQ, Krugh D, O’Shaughnessy RW. Journal: Obstet Gynecol;
332 26 2004 Jan ; 103(1):24-30. PubMed ID: 14704240 http://www.ncbi.nlm.nih.gov/pubmed/?term=14704240
Coombs Negative AIHA. Autoimmune Hemolytic Anemia in the Absence of a Positive http://autoimmunedisease.suite101.com/article.cfm/coom
332 27 DAT Test. E Moore 2008 bs_negative_aiha
Oxford Handbook of Clinical Medicine, 9th Edition - Chapter 8 references
Page No Final Ref No. Bibliographic information Website link (if applicable)
Thrombosis in paroxysmal nocturnal hemoglobinuria at a glance: a clinical review.
Author: Ziakas PD, Poulou LS, Pomoni A. Journal: Curr Vasc Pharmacol; 2008 Oct ;
332 28 6(4):347-53. PubMed ID: 18855722. http://www.ncbi.nlm.nih.gov/pubmed/?term=18855722
Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in
29 Italy FRANCO MARTINEZ DI MONTEMUROS. Haematologica 1997; 82:440-445 http://haematologica-thj.org/content/82/4/440.full.pdf
Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in
children with sickle cell anemia and abnormal results on transcranial Doppler
334 30 ultrasonography. N Engl J Med 1998; 339:5-11. http://www.ncbi.nlm.nih.gov/pubmed/?term=9647873
Treatment of priapism in pediatric patients with sickle cell disease. Author: Maples BL,
Hagemann TM. Journal: Am J Health Syst Pharm; 2004 Feb 15 ; 61(4):355-63. PubMed
334 31 ID: 15011763. http://www.ncbi.nlm.nih.gov/pubmed/?term=15011763
Zinc supplementation decreases oxidative stress, incidence of infection, and
generation of inflammatory cytokines in sickle cell disease patients. Author: Bao B,
Prasad AS, Beck FW, Snell D, Suneja A, Sarkar FH, Doshi N, Fitzgerald JT, Swerdlow P.
334 32 Journal: Transl Res; 2008 Aug ; 152(2):67-80. PubMed ID: 18674741. http://www.ncbi.nlm.nih.gov/pubmed/?term=18674741
Factors associated with sickle cell disease mortality among hospitalized Angolan
children and adolescents. Author: Van-Dunem JC, Alves JG, Bernardino L, Figueiroa JN,
Braga C, do Nascimento Mde L, da Silva SJ. Journal: West Afr J Med; 2007 Oct-Dec ;
334 33 26(4):269-73. PubMed ID: 18705424. http://www.ncbi.nlm.nih.gov/pubmed/?term=18705424
http://profile.myspace.com/index.cfm?fuseaction=user.vie
334 34 Blog of sickle cell disease wprofile&friendid=418449133
334 35 PS Bellett 1996 e-bm 1 76. No link available
334 36 J Williams. N Engl J Med 1993; 329: 472, 501. No link available
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retri
Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on frequency of painful eve&db=pubmed&dopt=Abstract&list_uids=7715639&que
334 37 crises in sickle cell anemia. N Engl J Med 1995; 332: 1317-1322. ry_hl=2
Steinberg MH, Barton F, Castro O, et al. Effect of hydroxyurea on mortality and
334 38 morbidity in adult sickle cell anemia. JAMA 2003; 289: 1645-1651. http://www.ncbi.nlm.nih.gov/pubmed/?term=12672732
Brit. Committee for Standards in Haem. Management of the acute painful crisis in http://www.bcshguidelines.com/documents/sicklecelldisea
335 39 sickle cell disease. British Journal of Haematology. 2003. se_bjh_2003.pdf
Causes and outcomes of the acute chest syndrome in sickle cell disease. National
335 40 Acute Chest Syndrome Study Group. http://www.ncbi.nlm.nih.gov/pubmed/?term=10861320
Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest
335 41 syndrome in sickle cell disease. N Engl J Med 2000; 342: 1855-1865. http://www.ncbi.nlm.nih.gov/pubmed/?term=10861320
335 42 P Gill 1998 bmj 317 761. No link available
Recent developments in iron chelation therapy. Author: Cario H, Janka-Schaub G,
Janssen G, Jarisch A, Strauss G, Kohne E. Journal: Klin Padiatr; 2007 May-Jun ;
336 43 219(3):158-65. PubMed ID: 17525910. http://www.ncbi.nlm.nih.gov/pubmed/?term=17525910
A randomized, double-blind, placebo-controlled trial of intravenous zoledronic acid in
the treatment of thalassemia-associated osteopenia. Author: Gilfillan CP, Strauss BJ,
Rodda CP, Bowden DK, Kean AM, Obaid M, Crawford BA. Journal: Calcif Tissue Int;
336 44 2006 Sep ; 79(3):138-44. PubMed ID: 16969592. http://www.ncbi.nlm.nih.gov/pubmed/?term=16969592
Effect of L-carnitine on the physical fitness of thalassemic patients. Author: El-
Beshlawy A, El Accaoui R, Abd El-Sattar M, Gamal El-Deen MH, Youssry I, Shaheen N,
Hamdy M, El-Ghamrawy M, Taher A. Journal: Ann Hematol; 2007 Jan ; 86(1):31-4.
336 45 PubMed ID: 17031691 http://www.ncbi.nlm.nih.gov/pubmed/?term=17031691
A randomized controlled 1-year study of daily deferiprone plus twice weekly
desferrioxamine compared with daily deferiprone monotherapy in patients with
thalassemia major. Author: Aydinok Y, Ulger Z, Nart D, Terzi A, Cetiner N, Ellis G,
Zimmermann A, Manz C. Journal: Haematologica; 2007 Dec ; 92(12):1599-606.
336 46 PubMed ID: 18055982. http://www.ncbi.nlm.nih.gov/pubmed/?term=18055982
A cross-sectional study of metabolic and endocrine complications in beta-thalassemia
major. Author: Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, Bahrami A,
Mobasri M, Niafar M, Khoshbaten M. Journal: Ann Saudi Med; 2008 Sep-Oct ;
336 47 28(5):361-6. PubMed ID: 18779644 http://www.ncbi.nlm.nih.gov/pubmed/?term=18779644
A randomized, double-blind, controlled trial of testosterone gel treatment versus
vehicle control on the facial hair of young men with beta-thalassemia major.Author:
Saeedi M, Kosaryan M, Fekri K, Adabi M, Mahdavi MR. Journal: J Dermatolog Treat;
336 48 2007 ; 18(5):271-4. PubMed ID: 17852629. http://www.ncbi.nlm.nih.gov/pubmed/?term=17852629
De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res.
336 49 2002; 58 Suppl 1:72-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=12373018
Acquired hemophilia: a case report. Author: Flisinski M, Windyga J, Stefanska E,
Huszcza S, Donderski R, Manitius J. Journal: Pol Arch Med Wewn; 2008 Apr ;
338 51 118(4):228-33. PubMed ID: 18575423. http://www.ncbi.nlm.nih.gov/pubmed/?term=18575423
Acquired hemophilia: a case report. Author: Flisinski M, Windyga J, Stefanska E,
Huszcza S, Donderski R, Manitius J. Journal: Pol Arch Med Wewn; 2008 Apr ; http://pubmedhh.nlm.nih.gov/cgi-
340 51 118(4):228-33. PubMed ID: 18575423. bin/abstract.cgi?id=18575423&from=cqsr
Bleeding time prolonged by daily low-dose aspirin is shortened by one medium dose
aspirin. Author: Yokoyama T, Yamasaki F, Yamashita K, Manabe M, Suwa K. Journal:
340 52 Acta Anaesthesiol Scand; 2008 Oct ; 52(9):1226-30. PubMed ID: 18823461. http://www.ncbi.nlm.nih.gov/pubmed/?term=18823461
Oxford Handbook of Clinical Medicine, 9th Edition - Chapter 8 references
Page No Final Ref No. Bibliographic information Website link (if applicable)
http://labtestsonline.org.au/understanding/analytes/platel
341 53 Platelet function tests et_function/glance-2.html
Can we predict bleeding? Author: Watson HG, Greaves M. Journal: Semin Thromb
341 54 Hemost; 2008 Feb ; 34(1):97-103. PubMed ID: 18393146. http://www.ncbi.nlm.nih.gov/pubmed/?term=18393146
A practical concept for preoperative identification of patients with impaired primary
hemostasis. Author: Koscielny J, Ziemer S, Radtke H, Schmutzler M, Pruss A, Sinha P,
Salama A, Kiesewetter H, Latza R. Journal: Clin Appl Thromb Hemost; 2004 Jul ;
341 55 10(3):195-204. PubMed ID: 15247976. http://www.ncbi.nlm.nih.gov/pubmed/?term=15247976
342 56 Handbook of Transfusion Medicine 2001 http://www.transfusionguidelines.org.uk/
Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-
pump coronary artery bypass surgery: a randomized trial. Author: Murphy GJ, Rogers
CS, Lansdowne WB, Channon I, Alwair H, Cohen A, Caputo M, Angelini GD. Journal: J
342 57 Thorac Cardiovasc Surg; 2005 Jul ; 130(1):20-8. PubMed ID: 15999036. http://www.ncbi.nlm.nih.gov/pubmed/?term=15999036
Relative cost of autologous red cell salvage versus allogeneic red cell transfusion
during abdominal aortic aneurysm repair. Author: Gardner A, Gibbs N, Evans C, Bell R.
342 58 Journal: Anaesth Intensive Care; 2000 Dec ; 28(6):646-9. PubMed ID: 11153290. http://www.ncbi.nlm.nih.gov/pubmed/?term=11153290
[Yes, we should keep ABO agglutination test within bedside transfusion checks.]
342 59 Journal: Transfus Clin Biol; 2008 Oct 16 ; ():. PubMed ID: 18930425 http://www.ncbi.nlm.nih.gov/pubmed/?term=18930425
A prospective, randomized, double-blind controlled trial of acetaminophen and
diphenhydramine pretransfusion medication versus placebo for the prevention of
343 60 transfusion reactions.Journal: Transfusion; 2008 Jul 30 ; ():. PubMed ID: 18673350. http://www.ncbi.nlm.nih.gov/pubmed/?term=18673350
Jehovah’s Witnesses’ blood policy. Sharp D. Lancet; 2000 Jul 1 ; 356(9223):8. PubMed http://www.thelancet.com/journals/lancet/article/PIIS014
343 61 ID: 10892756 0-6736%2800%2902424-7/fulltext
Treatment without consent: a medicolegal precedent. Yate RM, Milling MA,
343 62 McFadzean W. Lancet; 2000 Jul 1 ; 356(9223):69. PubMed ID: 10892780 http://www.ncbi.nlm.nih.gov/pubmed/?term=10892780
Brave new world: The current and future use of novel anticoagulants. Journal: Thromb
344 63 Res; 2008 Oct 1 ; ():. PubMed ID: 18835010. http://www.ncbi.nlm.nih.gov/pubmed/?term=18835010
Role of prophylactic antibiotics in the prevention of infections after chemotherapy: a
literature review. Author: Moon S, Williams S, Cullen M. Journal: Support Cancer Ther;
346 67 2006 Jul 1 ; 3(4):207-16. PubMed ID: 18632496. http://www.ncbi.nlm.nih.gov/pubmed/?term=18632496
Robert Philips BMJ 2012 345 47. Prevention and management of neutropenic sepsis in
64 patients with cancer: NICE 2012 www.bmj.com
Valganciclovir prevents cytomegalovirus reactivation in patients receiving
alemtuzumab-based therapy. Author: O’Brien S, Ravandi F, Riehl T, Wierda W, Huang
X, Tarrand J, O’Neal B, Kantarjian H, Keating M. Journal: Blood; 2008 Feb 15 ;
346 68 111(4):1816-9. PubMed ID: 18039954. http://www.ncbi.nlm.nih.gov/pubmed/?term=18326123
Elevation of serum C-reactive protein predicts failure of the initial antimicrobial
treatment for febrile neutropenia with lung cancer. Authors Matsumoto T, et al.
69 Show all Journal J Infect Chemother. 2012 Sep 28. http://www.ncbi.nlm.nih.gov/pubmed/?term=23053498
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk
factors and development of a predictive model. Author: Montesinos P, Lorenzo I,
Martín G, Sanz J, Pérez-Sirvent ML, Martínez D, Ortí G, Algarra L, Martínez J, Moscardó
F, de la Rubia J, Jarque I, Sanz G, Sanz MA. Journal: Haematologica; 2008 Jan ; 93(1):67-
346 65 74. PubMed ID: 18166787 http://www.ncbi.nlm.nih.gov/pubmed/?term=18166787
Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human
346 66 activated protein C for severe sepsis. N Engl J Med. 2001; 344: 699-709. http://www.ncbi.nlm.nih.gov/pubmed/?term=11236773
348 70 Dickinson HO. The causes of childhood leukaemia. BMJ 2005; 330:1279-80. http://www.ncbi.nlm.nih.gov/pubmed/?term=15933336
Interventions for improving communication with children and adolescents about their
348 71 cancer. Cochrane Rev; 2008. PubMed ID: 18843635. http://www.ncbi.nlm.nih.gov/pubmed/?term=18843635
A video game improves behavioral outcomes in adolescents and young adults with
cancer: a randomized trial. Author: Kato PM, Cole SW, Bradlyn AS, Pollock BH. Journal:
348 72 Pediatrics; 2008 Aug ; 122(2):e305-17. PubMed ID: 18676516. http://www.ncbi.nlm.nih.gov/pubmed/?term=18676516
Patients’ perceptions of having a central venous catheter or a totally implantable
subcutaneous port system-results from a randomised study in acute leukaemia.
348 73 Journal: Support Care Cancer; 2008 May 1 ; ():. PubMed ID: 18449573. http://www.ncbi.nlm.nih.gov/pubmed/?term=18449573
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is
achieved from a matched sibling allogeneic transplantation in first complete
remission, and an autologous transplantation is less effective than conventional
consolidation/maintenance chemotherapy in all patients: final results of the
348 74 International ALL Trial (MRC UKALL XII/ECOG E2993). http://www.ncbi.nlm.nih.gov/pubmed/?term=18048644
348 75 D Hoelzer 1993 N Engl J Med, 329; 1343. No link available
Anemia and survival in childhood acute lymphoblastic leukemia. Journal:
348 76 Haematologica; 2008 Sep 24. PubMed ID: 18815194 http://www.ncbi.nlm.nih.gov/pubmed/?term=18815194
Outcome after first relapse in adult patients with Philadelphia chromosome-negative
acute lymphoblastic leukaemia. Authors Kako S, et al. Show all Journal Br J
77 Haematol. 2013 Feb 1. doi: 10.1111/bjh.12225. http://www.ncbi.nlm.nih.gov/pubmed/?term=23368421
A Personalized Approach to Cancer Treatment: How Biomarkers Can Help. PubMed ID:
348 78 18801934 http://www.ncbi.nlm.nih.gov/pubmed/?term=18801934
Oxford Handbook of Clinical Medicine, 9th Edition - Chapter 8 references
Page No Final Ref No. Bibliographic information Website link (if applicable)
348 79 A Leonard 2000 bmj ii 433 http://www.bmj.com/cgi/content/full/321/7258/433
Effects of a walking intervention on fatigue-related experiences of hospitalized acute
myelogenous leukemia patients undergoing chemotherapy: a randomized controlled
trial. Author: Chang PH, Lai YH, Shun SC, Lin LY, Chen ML, Yang Y, Tsai JC, Huang GS,
Cheng SY. Journal: J Pain Symptom Manage; 2008 May ; 35(5):524-34. PubMed ID:
350 80 18280104. http://www.ncbi.nlm.nih.gov/pubmed/?term=18280104
Patients with acute myeloid leukemia and RAS mutations benefit most from
postremission high-dose cytarabine: a Cancer and Leukemia Group B study. Author:
Neubauer A, Maharry K, Mrózek K, Thiede C, Marcucci G, Paschka P, Mayer RJ, Larson
RA, Liu ET, Bloomfield CD. Journal: J Clin Oncol; 2008 Oct 1 ; 26(28):4603-9. PubMed
350 81 ID: 18559876. http://www.ncbi.nlm.nih.gov/pubmed/?term=18559876
Acute myeloid leukemia and the position of autologous stem cell transplantation.
Author: Breems DA, Löwenberg B. Journal: Semin Hematol; 2007 Oct ; 44(4):259-66.
350 82 PubMed ID: 17961725 http://www.ncbi.nlm.nih.gov/pubmed/?term=17961725
The evolving molecular genetic landscape in acute myeloid leukaemia. Authors
Sanders MA, et al. Show all Journal Curr Opin Hematol. 2013 Mar;20(2):79-85. doi:
83 10.1097/MOH.0b013e32835d821c. http://www.ncbi.nlm.nih.gov/pubmed/?term=23380602
http://www.thelancet.com/journals/lancet/article/PIIS014
352 84 Prof G Dighiero 2008 Lancet DOI:10.1016/S0140-6736(08)60456 0673608604560/fulltext
Chronic lymphocytic leukemia : Treatment and genetic risk profile. Authors
85 Stilgenbauer S, et al. Show all Journal Internist (Berl). 2013 Feb 1. http://www.ncbi.nlm.nih.gov/pubmed/?term=23371259
Assessment of fludarabine plus cyclophosphamide for patients with chronic
lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. Author:
352 86 Catovsky D http://www.ncbi.nlm.nih.gov/pubmed/?term=17658394
Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B
cell hematologic malignancies. Authors Gupta IV, et al. Show all Journal Ann N Y
88 Acad Sci. 2012 Aug;1263(1):43-56. doi: 10.1111/j.1749-6632.2012.06661.x. http://www.ncbi.nlm.nih.gov/pubmed/?term=22830942
Alemtuzumab for B-cell chronic lymphocytic leukemia. Author: Robak T. Journal:
352 87 Expert Rev Anticancer Ther; 2008 Jul ; 8(7):1033-51. PubMed ID: 18588450. http://www.ncbi.nlm.nih.gov/pubmed/?term=18588450
Rituximab in combination with high-dose dexamethasone for the treatment of
relapsed/refractory chronic lymphocytic leukemia. Authors Smolej L, et al. Show all
89 Journal Leuk Res. 2012 Oct;36(10):1278-82. doi: 10.1016/j.leukres.2012.07.005. http://www.ncbi.nlm.nih.gov/pubmed/?term=22840362
Chronic myeloid leukaemia. Author: Hehlmann R, Hochhaus A, Baccarani M, European
353 90 LeukemiaNet . Journal: Lancet; 2007 Jul 28 ; 370(9584):342-50. PubMed ID: 17662883. http://www.ncbi.nlm.nih.gov/pubmed/?term=17662883
Treating chronic myeloid leukemia. Authors Simoneau CA. Journal Clin J Oncol
91 Nurs. 2013 Feb 1;17(1):E13-20. doi: 10.1188/13.CJON.E13-E20. http://www.ncbi.nlm.nih.gov/pubmed/?term=23372106
Nice 2012. Leukaemia (chronic myeloid, first line) - dasatinib, nilotinib and standard-
92 dose imatinib (TA251). Who can have nilotinib or imatinib? http://guidance.nice.org.uk/TA251
New aspects in descriptive, etiologic, and molecular epidemiology of Hodgkin’s
lymphoma. Author: Landgren O, Caporaso NE. Journal: Hematol Oncol Clin North Am;
354 93 2007 Oct ; 21(5):825-40. PubMed ID: 17908622. http://www.ncbi.nlm.nih.gov/pubmed/?term=17908622
Obesity and risk of non-Hodgkin’s lymphoma: a meta-analysis. Author: Larsson SC,
354 94 Wolk A. Journal: Int J Cancer; 2007 Oct 1 ; 121(7):1564-70. PubMed ID: 17443495. http://www.ncbi.nlm.nih.gov/pubmed/?term=17443495
Risk, cure and complications in advanced hodgkin disease. Author: Horning SJ. Journal:
Hematology Am Soc Hematol Educ Program; 2007 ; 2007():197-203. PubMed ID:
354 95 18024630. http://www.ncbi.nlm.nih.gov/pubmed/?term=18024630
Patterns of disease progression and outcomes in a randomized trial testing ABVD
alone for patients with limited-stage Hodgkin lymphoma. Author: Macdonald DA, Ding
K, Gospodarowicz MK, Wells WA, Pearcey RG, Connors JM, Winter JN, Horning SJ,
Djurfeldt MS, Shepherd LE, Meyer RM. Journal: Ann Oncol; 2007 Oct ; 18(10):1680-4.
354 96 PubMed ID: 17846017. http://www.ncbi.nlm.nih.gov/pubmed/?term=17846017
http://www.thelancet.com/journals/lancet/article/PIIS014
354 97 Lancet 1997 349 34 & 664. 0-6736%2805%2962171-X/fulltext
Cancer Incidence and Survival in Adolescents and Young Adults in France, 2000-2008.
98 Authors Desandes E, et al. Show all Journal Pediatr Hematol Oncol. 2013 Jan 30. http://www.ncbi.nlm.nih.gov/pubmed/?term=23363314
Lymphographic demonstration of cyclic changes in lymph node size during Pel-Epstein
fever. Author: Scanlon GT, Castellino RA, Rudders R. Journal: Cancer; 1975 Dec ;
354 99 36(6):2026-8. PubMed ID: 1203860. http://www.ncbi.nlm.nih.gov/pubmed/?term=1203860
Comparing long-term toxicity and efficacy of combined modality treatment including
extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma. Authors
Sasse S, et al. Show all Journal Ann Oncol. 2012 Nov;23(11):2953-9. doi:
101 10.1093/annonc/mds110. http://www.ncbi.nlm.nih.gov/pubmed/?term=22767583
ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned.
100 NEJM 2011. http://www.nejm.org/doi/full/10.1056/NEJMoa1100340
Does self-affirmation, cognitive processing, or discovery of meaning explain cancer-
related health benefits of expressive writing? Author: Creswell JD, Lam S, Stanton AL,
Taylor SE, Bower JE, Sherman DK. Journal: Pers Soc Psychol Bull; 2007 Feb ; 33(2):238-
355 102 50. PubMed ID: 17259584. http://www.ncbi.nlm.nih.gov/pubmed/?term=17259584
no reviews yet
Please Login to review.
